To determine the effect of simvastatin on Th17 signature cytokine response in the airways of patients with COPD, IL-17A and IL-22 were quantified on the protein level in sputum supernatants of simvastatin- and placebo-treated patients with COPD. This evidence concerns the gene IL22 and chronic obstructive pulmonary disease.